Siddhesh Kamat

Regeneron (United States) ORCID: 0000-0001-5205-9184

1

h-index

1

Publications

1,335

Citations

Publications

1 shown

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert , Joseph K. Han , Martin Desrosiers +31 more

2019 The Lancet 1335 citations

Frequent Co-Authors

Claus Bachert

Ghent University Hospital

Joseph K. Han

Eastern Virginia Medical School

Martin Desrosiers

Université de Montréal

Peter W. Hellings

Ghent University Hospital

Nikhil Amin

National Institute for Health Research

Stella E. Lee

University of Pittsburgh Medical Center

Researcher Info

h-index: 1
Publications: 1
Citations: 1,335
Institution: Regeneron (United States)

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-5205-9184

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.